2022

COVID-19: new disease mechanism is simultaneously a therapeutic target.
Schmitt, C.A. ORCID: https://orcid.org/0000-0002-4731-2226
memo: Magazine of European Medical Oncology 15 (2): 100-101. June 2022

2020

ASH highlights 2019: "aggressive B-cell lymphoma".
Schmitt, C.A. ORCID: https://orcid.org/0000-0002-4731-2226
memo: Magazine of European Medical Oncology 13 (3): 266-269. 20 May 2020

Ensuring center quality, proper patient selection and fair access to chimeric antigen receptor T-cell therapy: position statement of the Austrian CAR-T Cell Network.
Greinix, H.T., Attarbaschi, A., Girschikofsky, M., Greil, R., Holter, W., Neumeister, P., Peters, C., Petzer, A., Rudzki, J., Schlenke, P., Schmitt, C.A. ORCID: https://orcid.org/0000-0002-4731-2226, Schwinger, W., Wolf, D., Worel, N. and Jaeger, U.
memo: Magazine of European Medical Oncology 13 (1): 27-31. March 2020

2019

Editorial: critical issues in lymphoma management.
Fuchs, D. ORCID: https://orcid.org/0000-0002-9968-1576 and Schmitt, C.A. ORCID: https://orcid.org/0000-0002-4731-2226
memo: Magazine of European Medical Oncology 12 (1): 1. March 2019